A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Adenovirus InfectionEBVCytomegalovirus InfectionsCytokine Capture SystemAllogenic Disease

Interventions

BIOLOGICAL

IFN-γ positive selected T-cells

Trial Locations (1)

RECRUITING

Universitätsspital Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER